Skip to main content
. 2017 Aug 9;23(5):227–232. doi: 10.5761/atcs.oa.17-00017

Table 1. Demographic data and comorbidities of patients.

  Group CCO (n = 35) n (%) Group NO-CCO (n = 266) n (%) Total % (n) (n = 301) n (%) P value

Group distribution 35 (11.6) 266 (88.4) 301 (100)  
Patients’ characteristics        
 Men 27 (77.1) 219 (82.3) 246 (81.7) 0.485
 Age (years) 65.1 ± 7.13 66.1 ± 8.89 65.97 ± 8.71 0.51
 Smoker 19 (54.3) 99 (37.2) 118 (39.2) 0.065
 In-hospital days 22.0 ± 9.4 20.7 ± 11.6 20.85 ± 11.39 0.515
Comorbidities        
 CAD 12 (34.3) 71 (26.7) 83 (27.6) 0.345
 PAD 8 (22.9) 35 (13.2) 43 (14.3) 0.123
 Hypertension 24 (68.6) 199 (74.8) 223 (74.1) 0.428
 Diabetes 16 (45.7) 111 (41.7) 127 (42.2) 0.853
 Previous CI 12 (34.3) 81 (30.5) 93 (30.9) 0.644
 Dyslipidemia 11 (31.4) 77 (28.9) 88 (29.2) 0.762
 Renal insufficiency 1 (2.9) 15 (5.6) 16 (5.3) 0.490
Symptoms        
 Asymptomatic 21 (60.0) 136 (51.1) 157 (52.2) 0.323
 TIA 7 (20.0) 57 (21.4) 64 (21.3)  
 Amaurosis 0 (0) 21 (7.9) 21 (6.9)  
 Stroke 7 (20.0) 52 (19.5) 59 (19.6)  

CAD: coronary artery disease; PAD: peripheral artery disease; TIA: transient ischemic attack; CI: cerebral infarction; CCO: contralateral carotid occlusion; NO-CCO: without CCO